Creative Planning’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.11M | Buy |
111,205
+47,309
| +74% | +$1.94M | ﹤0.01% | 1251 |
|
|
2026
Q1 | $2.12M | Buy |
63,896
+1,007
| +2% | +$30K | ﹤0.01% | 1843 |
|
|
2025
Q4 | $1.87M | Sell |
62,889
-13,419
| -18% | -$438K | ﹤0.01% | 1771 |
|
|
2025
Q3 | $2.76M | Sell |
76,308
-4,445
| -6% | -$146K | ﹤0.01% | 1289 |
|
|
2025
Q2 | $2.91M | Sell |
80,753
-7,534
| -9% | -$280K | ﹤0.01% | 1054 |
|
|
2025
Q1 | $3.48M | Buy |
88,287
+29,427
| +50% | +$990K | ﹤0.01% | 863 |
|
|
2024
Q4 | $1.77M | Buy |
58,860
+3,028
| +5% | +$86.9K | ﹤0.01% | 1215 |
|
|
2024
Q3 | $1.31M | Buy |
55,832
+8,993
| +19% | +$196K | ﹤0.01% | 1323 |
|
|
2024
Q2 | $833K | Buy |
46,839
+12,076
| +35% | +$193K | ﹤0.01% | 1555 |
|
|
2024
Q1 | $529K | Buy |
34,763
+5,958
| +21% | +$94.9K | ﹤0.01% | 1814 |
|
|
2023
Q4 | $492K | Buy |
28,805
+3,181
| +12% | +$37K | ﹤0.01% | 1725 |
|
|
2023
Q3 | $214K | Sell |
25,624
-1,474
| -5% | -$20.5K | ﹤0.01% | 2188 |
|
|
2023
Q2 | $673K | Buy |
27,098
+1,297
| +5% | +$33.5K | ﹤0.01% | 1372 |
|
|
2023
Q1 | $388K | Buy |
25,801
+971
| +4% | +$14.7K | ﹤0.01% | 1641 |
|
|
2022
Q4 | $294K | Sell |
24,830
-218
| -0.9% | -$1.58K | ﹤0.01% | 1740 |
|
|
2022
Q3 | $148K | Buy |
25,048
+167
| +0.7% | +$1.09K | ﹤0.01% | 1974 |
|
|
2022
Q2 | $106K | Buy |
+24,881
| New | +$155K | ﹤0.01% | 1965 |
|
|
2022
Q1 | – | Sell |
-80,956
| Closed | -$1.54M | – | 2439 |
|
|
2021
Q4 | $1.54M | Buy |
80,956
+54,716
| +209% | +$1.42M | ﹤0.01% | 781 |
|
|
2021
Q3 | $873K | Buy |
26,240
+6,110
| +30% | +$189K | ﹤0.01% | 1013 |
|
|
2021
Q2 | $781K | Buy |
20,130
+8,829
| +78% | +$347K | ﹤0.01% | 1049 |
|
|
2021
Q1 | $545K | Buy |
11,301
+1,850
| +20% | +$88.9K | ﹤0.01% | 1378 |
|
|
2020
Q4 | $492K | Buy |
+9,451
| New | +$319K | ﹤0.01% | 1322 |
|
|
2018
Q2 | – | Sell |
-10,561
| Closed | -$150K | – | 2170 |
|
|
2018
Q1 | $150K | Buy |
+10,561
| New | +$135K | ﹤0.01% | 1677 |
|
|
2017
Q3 | – | Sell |
-4,000
| Closed | -$40K | – | 3538 |
|
|
2017
Q2 | $40K | Sell |
4,000
-28,001
| -88% | -$313K | ﹤0.01% | 2688 |
|
|
2017
Q1 | $373K | Buy |
32,001
+1,000
| +3% | +$7.18K | ﹤0.01% | 1140 |
|
|
2016
Q4 | $144K | Buy |
31,001
+901
| +3% | +$5.28K | ﹤0.01% | 1614 |
|
|
2016
Q3 | $233K | Sell |
30,100
-2,047
| -6% | -$13.2K | ﹤0.01% | 1319 |
|
|
2016
Q2 | $195K | Hold |
32,147
| – | – | ﹤0.01% | 1264 |
|
|
2016
Q1 | $274K | Sell |
32,147
-5,301
| -14% | -$46.4K | ﹤0.01% | 1049 |
|
|
2015
Q4 | $447K | Buy |
37,448
+3,200
| +9% | +$40.4K | ﹤0.01% | 817 |
|
|
2015
Q3 | $345K | Buy |
34,248
+800
| +2% | +$11.9K | ﹤0.01% | 901 |
|
|
2015
Q2 | $555K | Buy |
33,448
+8,000
| +31% | +$127K | 0.01% | 635 |
|
|
2015
Q1 | $394K | Buy |
25,448
+648
| +3% | +$9.81K | ﹤0.01% | 842 |
|
|
2014
Q4 | $393K | Buy |
24,800
+10,000
| +68% | +$130K | ﹤0.01% | 794 |
|
|
2014
Q3 | $158K | Buy |
+14,800
| New | +$137K | ﹤0.01% | 1197 |
|
Other funds holding TGTX
SCM
CAM
Creative Planning's TGTX Position: Q2 2026 in Review
Creative Planning increased its TG Therapeutics (TGTX) stake by 74% in Q2 2026, buying an estimated $1.94M and bringing the position to 111,205 shares worth $6.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1251.
Creative Planning first reported a position in TGTX in Q3 2014 and has held it in 35 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Creative Planning held 111,205 shares of TG Therapeutics worth $6.11M as of Q2 2026.
- Creative Planning bought 47,309 TG Therapeutics shares in Q2 2026, an estimated $1.94M.
- TG Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1251 holding.
- Creative Planning first reported a position in TG Therapeutics in Q3 2014 and has held it in 35 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.